SofPulse® offers an FDA-cleared medical device that reduces post-operative pain, inflammation and edema cutting opioid use up to 70%.

With 50 million surgical patients yearly in the US, an additional 15 million Veterans and millions of Americans retiring to Elder Care and Assisted living facilities yearly (where 1 out of 10 is at risk of bedsores or chronic wounds yearly), SofPulse® is in the position to make major difference in drug-free pain management and speeding up recovery.

With plans to secure Insurance medical reimbursement, SofPulse® aims to become the standard of care for reducing opioid use, accelerating recovery and reducing healthcare costs which will help us save lives.

Join us to help fight the opioid crisis. Invest now and be part of the solution!

Goal: Raise funds to achieve insurance medical reimbursement for SofPulse® FDA-cleared device, enabling widespread adoption in the US surgical markets, VA/DoD and the aging U.S. Eldercare markets so we can significantly reduce opioid use and dependency for pain relief.

Future projections are not guaranteed.

The opioid crisis has been ravaging communities and families across the United States for the past decade.

More than 560,000 people in the United States have died from overdoses involving opioids since the epidemic began; The number of annual opioid overdose deaths remains more than 8 times higher than it was in 1999; There were approximately 80,000 overdose deaths in 2024.

SofPulse is stepping up to tackle this monumental challenge in the healthcare market

The Opioid Crisis:

According to the National Center for Drug Abuse (NCDAS) Opioids are the deadliest drug type:

· 4 out of 5 people using heroin first misused prescription Opioids.

· At least one type of opioid is a factor in 7 out of 10 Overdose deaths.

· Overdose deaths rank just below diabetes in terms of highest death count.

· Killing more than 230 Americans every day.

· Drug overdoses have killed almost a million people since 1999.

It is clear that we need safer, effective alternatives for opioids as well as finding ways to reduce their use.

SofPulse® technology effectively alleviates pain associated with surgical procedures and chronic inflammatory conditions, reducing the need for opioid medications. By providing safe and effective pain management, we aim to minimize the risks associated with opioid use, including dependency and adverse side effects.

In postoperative care, SofPulse® devices not only enhances recovery but also works to prevent possible escalation into opioid dependency.

The VHA and DoD are presently evaluating SofPulse® devices as a solution for reducing opioid use in post-surgical pain, wound management and breakthrough pain experienced prior to surgery. SofPulse®’s inclusion in the Federal Supply Schedule opens doors to the largest integrated healthcare system in the US.

Our heroes often face challenges with pain and recovery, making them key beneficiaries of the SofPulse® solution.

SofPulse has quickly established itself as a leader in the emerging medical device space, delivering innovative, and non-invasive treatments that address pressing needs in patient care.

Our FDA-cleared medical device for postoperative reduction in pain and edema as well as in the promotion of wound recovery provides effective palliative care, particularly for vulnerable populations such as the elderly and those with limited mobility.

SofPulse® medical devices have 18 granted patents for treating pain and inflammation related conditions including: Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Inflammation, Strokes and other related conditions with PEMF (Pulsed Electromagnetic Frequency) therapy.

SofPulse is the only therapeutic option to treat pain after surgery other than a NSAID which is far less effective. The superior effects, we believe, enable this technology to be the "go to pain" management option upon receiving Medical Reimbursement - we believe this will change the world and enables our supporters to see a geometric return!

FDA cleared for its adjunctive use in reduction and treatment of postoperative pain and edema, SofPulse® has shown clinical efficacy in postoperative use to have a 3X reduction of pain mean scores, 275% reduction in postoperative inflammation and edema, and a 2.2-fold reduction in the need for pain medication compared to placebo treatments - without known side effects or contraindications.

Additionally, an investigator-initiated study, authored by Dr. Samir Awad, Professor of Surgery at Baylor College of Medicine, entitled ‘The Impact of Pulsed Electromagnetic Field (SofPulse®) on Postoperative Pain in Patients Undergoing Cardiothoracic Surgery’ demonstrate that the use of SofPulse® significantly decreased postoperative pain by 50%, decreased opioid requirements by 70%, and resulted in a significant decrease in Length of Stay at the hospital by a median of 2 days.

SofPulse® currently stands as the only viable non-invasive, FDA-cleared product on the market that effectively reduces pain, edema, and inflammation while treating and preventing pressure ulcers.

The device has previously received CMS National Coverage for managing chronic wounds, reinforcing its clinical significance and providing reimbursement opportunities for healthcare providers.

Upon us completing a multi-site definitive trial to obtain Medical Reimbursement and bring SofPulse® to market, we expect Geometric Growth and Profit..

It is that simple; 50 million patients each year have surgical procedures and needing our device for a better result. 50 million x $500 is a total available market of $25 billion!

Future projections are not guaranteed.

Future projections are not guaranteed.

Future projections are not guaranteed.

Initial Raise:

Upon completing the audited financials for 2023 and 2024, we plan to file an amendment to increase the raise to $5,000,000.

We plan to file an S-1 with the SEC to register your shares and take the company public. Our goal is to become a NASDAQ or NYSE listed company shortly thereafter.

Future projections are not guaranteed.

Why Invest in SofPulse?

And You Can Get Perks:

Together, We Can Get SofPulse® Medical Reimbursement and Help Millions of People

By investing in SofPulse, you're helping us reduce the opioid consumption after surgery for all surgical patients. Let’s prevent addiction by making SofPulse® the standard of care in every Hospital stay and save lives daily.

We can:

1. Help society fix a horrible problem – Opioid Addiction!
2. Provide our investors an opportunity to make a substantial profit on their investment.

So let's help people consume less opioids!

Please join us in making this a reality.